Bridgebio Pharma shares owned by Gilder, Gagnon, Howe & Co
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Gilder, Gagnon, Howe & Co
from 13F filings
Historical chart of Gilder, Gagnon, Howe & Co investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bridgebio Pharma by Gilder, Gagnon, Howe & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.4M | 45k | 30.92 |
2023-12-31 | $1.6M | 40k | 40.37 |
2023-09-30 | $1.1M | 40k | 26.37 |
2023-06-30 | $612k | 36k | 17.20 |
2023-03-31 | $528k | 32k | 16.58 |
2022-12-31 | $248k | 33k | 7.62 |
2022-09-30 | $481k | 48k | 9.94 |
2022-06-30 | $443k | 49k | 9.09 |
2022-03-31 | $8.6M | 845k | 10.15 |
2021-12-31 | $14M | 845k | 16.68 |
2021-09-30 | $35M | 755k | 46.87 |
2021-06-30 | $46M | 758k | 60.96 |
2021-03-31 | $47M | 765k | 61.60 |